Diligence memo · auto-generated · as of July 2, 2026
Soleno Therapeutics Inc
Soleno Therapeutics Inc looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
Soleno Therapeutics Inc operates in Pharma, based in REDWOOD CITY.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Soleno Therapeutics Inc has raised $99M in disclosed capital across 10 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $60M on 2023-10-02.
Most recent recorded round closed around 2023-10-02.
Valuation (modeled)modeled
Provath models Soleno Therapeutics Inc at approximately $681M (range $195M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.07× the median modeled value of Series C Pharma companies in 2022–2024 (7 peers) — value vs value, same stage and era. Within the normal band (107% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 15 months.
Last raise 2.7 yr ago; this sector typically re-raises about every 16 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 4.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 90% of Pharma peers (310 compared).
Modeled value ranks above 88% of those peers.
Closest niche peers: Circle Pharma, Inc., Averna Therapeutics Inc., Progentos Therapeutics, Inc., Intrinsic Therapeutics Inc, Digital Therapeutics, Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.